OAK TREE MEDICAL SYSTEMS INC
8-K, 1997-05-06
HEALTH SERVICES
Previous: MPM TECHNOLOGIES INC, 8-K, 1997-05-06
Next: NUVEEN TAX FREE MONEY MARKET FUND INC, N-30D, 1997-05-06



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549



                                    FORM 8-K

                                 CURRENT REPORT

     PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934




Date of Report (Date of earliest event reported)      April 29, 1997



                         OAK TREE MEDICAL SYSTEMS, INC.
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


             Delaware                    0-16206                02-0401674
- --------------------------------------------------------------------------------
  (State or other jurisdiction         (Commission            (IRS Employer
         of incorporation)             File Number)         Identification No.)



           163-03 Horace Harding Expressway, Flushing, New York       11365
- --------------------------------------------------------------------------------
               (Address of principal executive offices)            (Zip Code)


Registrant's telephone number, including area code      (718) 961-5224



- --------------------------------------------------------------------------------
       (Former  name or former  address,  if changed  since last report.)







                                     Page 1


<PAGE>


ITEM 4.  CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT

(a)      Previous independent accountants

          (i)  On April 29, 1997 Oak Tree Medical Systems,  Inc. (the "Company")
               was  notified by the firm of Simon  Krowitz  Bolin &  Associates,
               P.A.,   that  they  were   resigning   from  the   client-auditor
               relationship.

          (ii) The report of Simon  Krowitz  Bolin &  Associates,  P.A.,  on the
               Company's financial statements for the last fiscal year contained
               no adverse opinion or disclaimer of opinion and was not qualified
               or  modified  as  to  uncertainty,   audit  scope  or  accounting
               principle.

          (iii)Subject to the  qualification  in the letter  from Simon  Krowitz
               Bolin & Associates,  P.A.,  attached as Exhibit 16, in connection
               with the audit of the Company's financial statements for its most
               recent fiscal year and through April 29, 1997, there have been no
               disagreements with Simon Krowitz Bolin & Associates, P.A., on any
               matter of accounting principles or practices, financial statement
               disclosure or auditing scope or procedure, which disagreements if
               not  resolved  to the  satisfaction  of  Simon  Krowitz  Bolin  &
               Associates,  P.A.,  would  have  caused  them to  make  reference
               thereto  in their  report on the  financial  statements  for such
               fiscal year.

          (iv) Subject to the  qualification  in the letter  from Simon  Krowitz
               Bolin & Associates, P.A., attached as Exhibit 16, during the most
               recent  fiscal year and through  April 29, 1997,  the Company was
               not advised of any of the matters  referred to in Regulation  S-B
               Item 304(a)(1)(iv)(B).

(b)      New independent accountants

          (i)  The Company has not yet appointed new independent accountants.


ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS

(c)      Exhibits

16   Copy of letter from Simon Krowitz Bolin &  Associates,  P.A.,  dated May 6,
     1997 addressed to the Securities and Exchange Commission


                                     Page 2


<PAGE>




                                   SIGNATURES


                  Pursuant to the requirements of the Securities Exchange Act of
1934,  the  Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.


                                            By:   /s/ Henry Dubbin
                                                  -------------------
                                                  Name:  Henry Dubbin
                                                  Title:    President


Date:  May 6, 1997



                                     Page 3







                                                                      EXHIBIT 16

                     SIMON KROWITZ BOLIN & ASSOCIATES, P.A.
                        11300 Rockville Pike, Suite 800
                              Rockville, MD 20852

May 6, 1997

Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C.  20549

Ladies and Gentlemen:

                  Re:      Oak Tree Medical Systems, Inc.

We have read Item 4 of the Form 8-K,  dated  May 6,  1997,  of Oak Tree  Medical
Systems, Inc. (the "Company") and are in agreement with the statements contained
in paragraph 4(a) therein, subject to the following qualification. Subsequent to
the  completion of our audit of the financial  statements of the Company for the
fiscal year ended May 31, 1996, we have not had sufficient  involvement with the
Company or its  accounting  practices and  procedures to enable us to comment on
such  accounting  practices  and  procedures  for any period  subsequent  to the
completion   of  our  audit,   including   the  matters   referred  to  in  Item
304(a)(1)(iv)(B) of Regulation S-B.

Yours very truly, 

/s/ SIMON KROWITZ BOLIN & ASSOCIATES, P.A.
- ------------------------------------------




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission